Literature DB >> 25568649

Clinical definition of sarcopenia.

Valter Santilli1, Andrea Bernetti1, Massimiliano Mangone1, Marco Paoloni1.   

Abstract

Sarcopenia is a condition characterized by loss of skeletal muscle mass and function. Although it is primarily a disease of the elderly, its development may be associated with conditions that are not exclusively seen in older persons. Sarcopenia is a syndrome characterized by progressive and generalized loss of skeletal muscle mass and strength and it is strictly correlated with physical disability, poor quality of life and death. Risk factors for sarcopenia include age, gender and level of physical activity. In conditions such as malignancy, rheumatoid arthritis and aging, lean body mass is lost while fat mass may be preserved or even increased. The loss in muscle mass may be associated with increased body fat so that despite normal weight there is marked weakness, this is a condition called sarcopenic obesity. There is an important correlation between inactivity and losses of muscle mass and strength, this suggests that physical activity should be a protective factor for the prevention but also the management of sarcopenia. Furthermore one of the first step to be taken for a person with sarcopenia or clinical frailty is to ensure that the sarcopenic patient is receiving correct and sufficient nutrition. Sarcopenia has a greater effect on survival. It should be important to prevent or postpone as much as possible the onset of this condition, to enhance survival and to reduce the demand for long-term care. Interventions for sarcopenia need to be developed with most attention on exercise and nutritional interventions.

Entities:  

Keywords:  epidemiology; sarcopenia; sarcopenic obesity; weakness

Year:  2014        PMID: 25568649      PMCID: PMC4269139     

Source DB:  PubMed          Journal:  Clin Cases Miner Bone Metab        ISSN: 1724-8914


  37 in total

1.  A prospective study of the associations between 25-hydroxy-vitamin D, sarcopenia progression and physical activity in older adults.

Authors:  David Scott; Leigh Blizzard; James Fell; Changhai Ding; Tania Winzenberg; Graeme Jones
Journal:  Clin Endocrinol (Oxf)       Date:  2010-11       Impact factor: 3.478

Review 2.  What is sarcopenia?

Authors:  W J Evans
Journal:  J Gerontol A Biol Sci Med Sci       Date:  1995-11       Impact factor: 6.053

3.  Frailty in older adults: evidence for a phenotype.

Authors:  L P Fried; C M Tangen; J Walston; A B Newman; C Hirsch; J Gottdiener; T Seeman; R Tracy; W J Kop; G Burke; M A McBurnie
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2001-03       Impact factor: 6.053

4.  Low serum concentrations of 25-hydroxyvitamin D in older persons and the risk of nursing home admission.

Authors:  Marjolein Visser; Dorly J H Deeg; Martine T E Puts; Jaap C Seidell; Paul Lips
Journal:  Am J Clin Nutr       Date:  2006-09       Impact factor: 7.045

5.  Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability.

Authors:  Ian Janssen; Steven B Heymsfield; Robert Ross
Journal:  J Am Geriatr Soc       Date:  2002-05       Impact factor: 5.562

6.  The healthcare costs of sarcopenia in the United States.

Authors:  Ian Janssen; Donald S Shepard; Peter T Katzmarzyk; Ronenn Roubenoff
Journal:  J Am Geriatr Soc       Date:  2004-01       Impact factor: 5.562

7.  The loss of skeletal muscle strength, mass, and quality in older adults: the health, aging and body composition study.

Authors:  Bret H Goodpaster; Seok Won Park; Tamara B Harris; Steven B Kritchevsky; Michael Nevitt; Ann V Schwartz; Eleanor M Simonsick; Frances A Tylavsky; Marjolein Visser; Anne B Newman
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2006-10       Impact factor: 6.053

Review 8.  Sarcopenic obesity: definition, cause and consequences.

Authors:  Sari Stenholm; Tamara B Harris; Taina Rantanen; Marjolein Visser; Stephen B Kritchevsky; Luigi Ferrucci
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2008-11       Impact factor: 4.294

9.  The mediating role of C-reactive protein and handgrip strength between obesity and walking limitation.

Authors:  Sari Stenholm; Taina Rantanen; Markku Heliövaara; Seppo Koskinen
Journal:  J Am Geriatr Soc       Date:  2007-12-27       Impact factor: 5.562

10.  Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) "cachexia-anorexia in chronic wasting diseases" and "nutrition in geriatrics".

Authors:  M Muscaritoli; S D Anker; J Argilés; Z Aversa; J M Bauer; G Biolo; Y Boirie; I Bosaeus; T Cederholm; P Costelli; K C Fearon; A Laviano; M Maggio; F Rossi Fanelli; S M Schneider; A Schols; C C Sieber
Journal:  Clin Nutr       Date:  2010-01-08       Impact factor: 7.324

View more
  166 in total

Review 1.  Frailty as a prognostic indicator in the radical cystectomy population: a review.

Authors:  Niki Parikh; Pranav Sharma
Journal:  Int Urol Nephrol       Date:  2019-06-07       Impact factor: 2.370

Review 2.  Sarcopenia in Alcoholic Liver Disease: Clinical and Molecular Advances.

Authors:  Jaividhya Dasarathy; Arthur J McCullough; Srinivasan Dasarathy
Journal:  Alcohol Clin Exp Res       Date:  2017-07-11       Impact factor: 3.455

3.  Genetic and epigenetic Muller's ratchet as a mechanism of frailty and morbidity during aging: a demographic genetic model.

Authors:  Hideki Innan; Reiner Veitia; Diddahally R Govindaraju
Journal:  Hum Genet       Date:  2019-11-11       Impact factor: 4.132

4.  Combined Effect of Sarcopenia and Systemic Inflammation on Survival in Patients with Advanced Stage Cancer Treated with Immunotherapy.

Authors:  Mehmet Asim Bilen; Dylan J Martini; Yuan Liu; Julie M Shabto; Jacqueline T Brown; Milton Williams; Amir I Khan; Alexandra Speak; Colleen Lewis; Hannah Collins; Haydn T Kissick; Bradley C Carthon; Mehmet Akce; Walid L Shaib; Olatunji B Alese; Rathi N Pillai; Conor E Steuer; Christina S Wu; David H Lawson; Ragini R Kudchadkar; Bassel F El-Rayes; Suresh S Ramalingam; Taofeek K Owonikoko; R Donald Harvey; Viraj A Master
Journal:  Oncologist       Date:  2019-12-05

Review 5.  Muscle-Bone Crosstalk in Chronic Kidney Disease: The Potential Modulatory Effects of Exercise.

Authors:  Diogo V Leal; Aníbal Ferreira; Emma L Watson; Kenneth R Wilund; João L Viana
Journal:  Calcif Tissue Int       Date:  2021-01-02       Impact factor: 4.333

Review 6.  Anabolism to Catabolism: Serologic Clues to Nutritional Status in Heart Failure.

Authors:  Laura Murphy; Alastair Gray; Emer Joyce
Journal:  Curr Heart Fail Rep       Date:  2019-10

Review 7.  Malnutrition in Older Adults with Cancer.

Authors:  Xiaotao Zhang; Beatrice J Edwards
Journal:  Curr Oncol Rep       Date:  2019-07-29       Impact factor: 5.075

Review 8.  Sarcopenia in gastric cancer: when the loss costs too much.

Authors:  Elena Ongaro; Vanessa Buoro; Marika Cinausero; Riccardo Caccialanza; Annalisa Turri; Valentina Fanotto; Debora Basile; Maria Grazia Vitale; Paola Ermacora; Giovanni Gerardo Cardellino; Laura Nicoletti; Lorenzo Fornaro; Andrea Casadei-Gardini; Giuseppe Aprile
Journal:  Gastric Cancer       Date:  2017-05-05       Impact factor: 7.370

Review 9.  Muscle wasting and cachexia in heart failure: mechanisms and therapies.

Authors:  Stephan von Haehling; Nicole Ebner; Marcelo R Dos Santos; Jochen Springer; Stefan D Anker
Journal:  Nat Rev Cardiol       Date:  2017-04-24       Impact factor: 32.419

10.  Sarcopenia is Associated with Nonunion of Open Tibia and Ankle Fractures.

Authors:  Wyatt Vander Voort; John Davison; Nathan Hendrickson; Joseph Buckwalter; Brian Guetschow; Natalie Glass; Michael Willey
Journal:  Iowa Orthop J       Date:  2020
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.